New pharmaceuticals and medical technologies are critically important to health. GHJP undertakes research and advocacy to ensure more integrity and transparency in clinical research and to bring about a more just system for the development and distribution of medicines. We believe that medicines should be available on equitable terms in all countries, and that reforms to our research and development (R&D) system are both possible, and needed, to make medicines more affordable, and to ensure that they are developed in response to health needs.

Rights related to gender and sexuality face both incremental progress and significant rollbacks of support in health and legal policy, with contestations often treated as constitutive of struggles between and within nations and cultures. Despite being delineated as a coherent field of rights, these struggles arise in remarkably asymmetrical ways: in some places, abortion rights are being rolled back, while gay rights are advancing; in some places, persons expressing gender and reproductive non-conformity are targeted, often through the criminal law. GHJP works in this complex and volatile area using a nuanced, multidisciplinary approach, moving between practice and scholarship to forge new alliances and provide analytics and groundwork for new policies.

Pathogens do not respect borders, and background conditions of inequality mean that certain people—particularly the poor and—predictably suffer the most when new health risks emerge. GHJP’s work in this area focuses on key structural factors associated with the transmission and effects of infectious disease, marshaling existing data, and doing new research to support public health and clinical interventions, social and political initiatives that will lessen risks and harms.

Global health justice issues are deeply entwined with disciplines that speak in numbers, in the epidemiological and clinical toll of these diseases, and their economic costs. GHJP mobilizes a variety of disciplines from operations research and management science, epidemiology and mathematical modeling of disease, statistics and probability to investigate ways to understand key issues in global health justice and their individual and societal impacts, and to shape solutions through modeling and assessing alternatives for interventions.